ZyVersa Therapeutics Inc. (ZVSA)
NASDAQ: ZVSA
· Real-Time Price · USD
0.31
-0.24 (-43.53%)
At close: Jul 16, 2025, 3:59 PM
ZyVersa Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 15.6K | 15.6K | 15.6K | 15.6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 15.64K | 26.08K | 15.64K | 18.24K | 18.24K | 10.4K | 10.4K | 10.4K | 10.4K | 10.4K | 7.8K | 7.8K | 7.8K | 7.8K | 7.8K | 5.2K | 2.6K |
Gross Profit | 10.44K | n/a | -39 | -2.64K | -2.64K | 5.2K | -10.4K | -10.4K | -10.4K | -10.4K | -7.8K | -7.8K | -7.8K | -7.8K | -7.8K | -5.2K | -2.6K |
Operating Income | -2.15B | -9.14M | -9.63M | -10.26M | -93.83M | -95.6M | -98.19M | -98.68M | -14.24M | -13.01M | -10.42M | -9.14M | -9.11M | -7.7M | -5.93M | -3.81M | -1.96M |
Interest Income | n/a | n/a | n/a | 0.21 | 0.52 | 1.08K | 1.08K | 1.15K | 106.26K | 109.64K | 109.64K | 109.57K | 4.45K | 169.82 | 169.82 | 169.82 | 169.82 |
Pretax Income | -4.66B | -2.41B | -2.42B | -22.42M | -105.99M | -107.75M | -98.42M | -99.21M | -14.89M | -14.05M | -11.41M | -9.6M | -9.69M | -8.08M | -6.12M | -4.24M | -2.14M |
Net Income | -4.66B | -2.41B | -2.42B | -21.83M | -97.58M | -98.3M | -89.75M | -90.59M | -13.87M | -13.99M | -11.17M | -9.31M | -9.61M | -8.08M | -6.12M | -4.24M | -2.14M |
Selling & General & Admin | 1.89B | 7.34M | 7.7M | 8.09M | 9.98M | 11.21M | 12.77M | 11.61M | 8.84M | 7.61M | 5.67M | 6.32M | 6.5M | 5.57M | 4.43M | 2.72M | 1.37M |
Research & Development | 260.14M | 1.78M | 1.92M | 2.15M | 2.66M | 3.21M | 4.24M | 5.9M | 5.4M | 5.41M | 4.75M | 2.83M | 2.6M | 2.12M | 1.49M | 1.08M | 586.85K |
Other Expenses | n/a | n/a | 93.25B | 93.25B | 93.33B | 93.33B | 81.17M | 81.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.15B | 9.12M | 9.61M | 10.24M | 12.64M | 14.42M | 17.01M | 17.5M | 14.24M | 13.01M | 10.42M | 9.14M | 9.11M | 7.7M | 5.92M | 3.81M | 1.96M |
Interest Expense | 119.83M | 269.86K | 131.79K | 369.00 | 625.00 | 524.00 | 50.25K | 119.39K | 259.48K | 427.54K | 582.54K | 738.67K | 598.27K | 430.2K | 225.49K | n/a | n/a |
Selling & Marketing Expenses | -1.83B | -4.14B | -4.14B | -2.31B | -2.31B | -2.6K | n/a | n/a | n/a | n/a | n/a | n/a | 1.35M | 2.72M | 2.72M | 2.72M | 1.37M |
Cost & Expenses | 3.74M | 6.56M | 9.63M | 10.26M | 12.66M | 14.42M | 17.01M | 17.5M | 14.24M | 13.01M | 10.42M | 9.14M | 9.11M | 7.7M | 5.93M | 3.81M | 1.96M |
Income Tax Expense | 6.75K | 6.75K | -586.36K | -586.85K | -8.41M | -9.46M | -8.67M | -8.63M | -1.02M | -61.77K | -55.65K | -103.2K | 107.02K | 192.52K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.11M | 1.09M | 988.38K | 834.91K | 623.6K | 405.2K | 88.51K | 51.02K | 26.08K | 25.95K | 46.55K | 46.55K | 46.55K | 28.65K | 46.55K | 46.55K | 46.55K |
Shares Outstanding (Diluted) | 3.11M | 1.09M | 988.38K | 834.91K | 623.6K | 405.2K | 88.51K | 51.02K | 26.08K | 25.95K | 46.55K | 46.55K | 46.55K | 28.65K | 46.55K | 46.55K | 46.55K |
EPS (Basic) | -7.78 | -11.58 | -43.19 | -73.92 | -1.76K | -1.9K | -2.04K | -2.3K | -653.66 | -598.3 | -426.37 | -179.4 | -174.23 | -139.68 | -131.36 | -90.98 | -45.97 |
EPS (Diluted) | -7.78 | -11.58 | -43.19 | -73.92 | -1.76K | -1.9K | -2.04K | -2.3K | -653.66 | -598.3 | -426.37 | -179.4 | -174.23 | -139.68 | -131.36 | -90.98 | -45.97 |
EBITDA | -2.15B | -9.12M | -21.77M | -22.4M | -24.8M | -26.57M | -18.01M | -18.73M | -15.46M | -14.45M | -10.85M | -8.88M | -8.85M | -7.23M | -5.46M | -3.81M | -1.96M |
EBIT | -6.31M | -9.14M | -9.63M | -10.26M | -12.66M | -14.42M | -18.02M | -18.74M | -15.47M | -14.46M | -10.85M | -8.88M | -8.87M | -7.26M | -5.5M | -3.84M | -1.97M |
Depreciation & Amortization | 4.33K | 14.77K | 17.37K | 18.24K | 18.24K | 10.4K | 10.4K | 10.4K | 10.4K | 10.4K | 10.4K | 10.4K | 10.4K | 10.4K | 7.8K | 5.2K | 2.6K |